Skip to main content

CORRECTION article

Front. Pharmacol., 11 October 2021
Sec. Cardiovascular and Smooth Muscle Pharmacology

Corrigendum: Functioning of Long Noncoding RNAs Expressed in Macrophage in the Development of Atherosclerosis

Xirui MaXirui MaHuifang Liu
Huifang Liu*Fengling Chen
Fengling Chen*
  • Department of Endocrinology and Metabolism, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

A corrigendum on
Functioning of Long Noncoding RNAs Expressed in Macrophage in the Development of Atherosclerosis

by Ma, X., Liu, H., and Chen, F. (2020). Front. Pharmacol. 11:567582. doi: 10.3389/fphar.2020.567582

In the original article, we neglected to include the funder “The National Natural Science Foundation of China, No. 81670735 to FC, The National Natural Science Foundation of China, No. 81400802 and Outstanding Youth Training Project from Shanghai Ninth People’s Hospital the National Natural Science Foundation of China, jyyq 08201607 to HL”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Funding

The National Natural Science Foundation of China, No. 81670735 to FC. The National Natural Science Foundation of China, No. 81400802 and Outstanding Youth Training Project from Shanghai Ninth People’s Hospital the National Natural Science Foundation of China, jyyq 08201607 to HL.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: long noncoding RNA, Atherosclerosis, macrophage, NF-kappa B, foam cell macrophage

Citation: Ma X, Liu H and Chen F (2021) Corrigendum: Functioning of Long Noncoding RNAs Expressed in Macrophage in the Development of Atherosclerosis. Front. Pharmacol. 12:767272. doi: 10.3389/fphar.2021.767272

Received: 02 September 2021; Accepted: 22 September 2021;
Published: 11 October 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Ma, Liu and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Huifang Liu, lhf_404@163.com; Fengling Chen, chenfl1101@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.